BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 14, 2010
View Archived Issues
New inhibitors of TNF-alpha release disclosed
Read More
Actelion identifies new antimalarial agents
Read More
NeuroSearch describes new monoamine reuptake inhibitors
Read More
Ortho-McNeil-Janssen and Addex claim new mGlu2 receptor modulators
Read More
FDA grants fast track status to Collegium's tamper-resistant COL-172
Read More
Phase III apixaban trial closed early due to clear evidence of efficacy
Read More
Dystrophin-based gene therapy evaluated in Duchenne's muscular dystrophy
Read More
Dainippon Sumitomo Pharma discloses last year's highlights
Read More
MRX-4 improves several symptoms of grass pollen allergy
Read More
Trials suggest dasatinib or nilotinib could replace imatinib as first-line CML therapy
Read More
ANR-94 is active in rodent models of Parkinson's disease
Read More
Cediranib to enter phase II trial in advanced biliary tract cancers
Read More
Onset advances COL-177 and COL-179 for skin conditions
Read More
Pfizer and Eisai to launch Lyrica in Japan for postherpetic neuralgia
Read More
MannKind's Afrezza noninferior to lispro in type 1 diabetes
Read More
FDA lifts clinical hold on Repros Therapeutics' Proellex
Read More
Human Genome Sciences submits BLA to FDA for Benlysta
Read More
Preliminary phase II data released on Surfaxin in children with ARF
Read More
Idenix begins phase I/II trial of IDX-320 in chronic hepatitis C
Read More
PurGenesis begins phase IIa PUR-0110 trial in distal ulcerative colitis
Read More
Cadila Healthcare launches Vaxiflu-S H1N1 vaccine in India
Read More
MonoSol Rx and APR Applied Pharma Research expand collaboration
Read More
RXi confirms new therapeutic strategy for novel RNAi technology
Read More
Health Canada approves Novartis' Menveo vaccine
Read More
FDA extends PDUFA date for Acthar sNDA for infantile spasms
Read More